National Health Reference Price List: Draft changes for Version 2.06

Similar documents
Occupational and Art Therapy 2006

NHS Circular: PCA(M)(2011)4 abcdefghijklmnopqrstu TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH SEVERE DISTRESS. Summary

2. The date of implementation of Version is Wednesday 18 January 2006.

Changes to the National Diabetes Services Scheme (NDSS)

Proposed Radiation Safety Regulations: Submission form

The Role of the Responsible Pharmacist (RP)

Occupational Therapy 2004

Access Points: Frequently Asked Questions 15 June 2016

Medical gap arrangements - practitioner application

New regulatory requirements DPCS Regulations 2017

HIV Programme. Overview. About some of the terms we use in this document

Guide to Professional Conduct and Ethics for Registered Medical Practitioners. Relationships between doctors and industry Frequently Asked Questions

TAILOR-MADE ALWAYS A BETTER FIT

RFQ:-HPCSA 03/2017 REQUEST FOR QUOTATION FOR OCCUPATIONAL HEALTH SERVICE ON BEHALF OF THE HEALTH PROFESSIONS COUNCIL OF SOUTH AFRICA

Physiotherapy Tender Questions and Answers

Oncology Programme 2017

Recall Guidelines. for Chinese Medicine Products

STAKEHOLDER CONSULTATION

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Dear Colleague SUPPLEMENTARY INFORMATION ON CANNABIS BASED PRODUCTS FOR MEDICINAL USE

Physical therapists also may be certified as clinical specialists through the American Board of Physical Therapy Specialists (ABPTS).

Presentation to Parliamentary Portfolio Committee on Health

NHS: 2001 PCA(D)8 abcdefghijklm

Consultancy Support Services for the Procurement of LEU for the establishment of the IAEA LEU Bank

Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof

PHYSICAL MEDICINE AND REHABILITATION CSHCN SERVICES PROGRAM PROVIDER MANUAL

Oncology Benefit 2018

STATUTORY INSTRUMENTS. S.I. No. 488 of 2008 REGULATION OF RETAIL PHARMACY BUSINESSES REGULATIONS 2008

Dispensing and administration of emergency opioid antagonist without a

(A) results from that individual's participation in or training for sports, fitness training, or other athletic competition; or

Report. Uganda Pharmaceutical Sector Scan JUNE 2010

Agency Information Collection Activities; Submission for Office of Management and Budget

Access to electronic communications services for disabled customers

Oncology Programme 2017

AFFORDABLE BENEFITS GUIDE. #caring4life

Supplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016.

Business Impact Analysis

Government Gazette Staatskoerant

Impact Summary: Therapeutic Products Bill Personal Import of Medicine by mail/courier

New hepatitis C medicines Frequently Asked Questions

Family Coverage Self-Only Coverage Amounts Per Accumulation Period (a Family of one Member) or more Members

= eé~äíü=aéé~êíãéåí= = aáêéåíçê~íé=çñ=mêáã~êó=`~êé=~åç=`çããìåáíó=`~êé= = mêáã~êó=`~êé=aáîáëáçå=

16 February 2009 SUBMISSION BY THE SOUTH AFRICAN MEDICAL DEVICE INDUSTRY ASSOCIATION (SAMED)

USE OF UNLICENSED MEDICINES AND OFF-LABEL MEDICINES WHERE A LICENSED MEDICINE IS AVAILABLE

Code of Practice for Radiation Protection in Dentistry. Code of Practice For Radiation Protection in Dentistry

An Overview of CPAP Services in Australian Community Pharmacies

Principal benefits for Kaiser Permanente Traditional HMO Plan (10/1/18 9/30/19)

Policy for Authorisation of Independent Vaccinators

The Radiation Health and Safety Act, 1985

Writing a PBS-RPBS prescription authorised optometrists

Government Gazette REPUBLIC OF SOUTH AFRICA

Interstate dispensing : A case for uniform, intuitive legislation

Principal Benefits for Kaiser Permanente Senior Advantage (HMO) with Part D (7/1/18 6/30/19)

Mary Ann Hodorowicz RDN, MBA, CDE, CEC (Certified

COURSE: Dental Radiography

XOSERVE LIMITED SERVICES SCHEDULE FOR THE PROVISION OF NON-CODE USER PAYS SERVICES (REFERENCE NUMBER XNCUP(SS)06) DATED 20 INTRODUCTION

VWA expectations for the delivery of osteopathic services to injured workers

Principal Benefits for Kaiser Permanente Traditional Plan (10/1/16 9/30/17)

Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology )

Summary of Benefits Chart for Kaiser Permanente Senior Advantage (HMO) with Part D (10/1/17 9/30/18)

SECTION PRESCRIPTIONS

ANNEXURE A SUPPLIER DECLARATION FORM P a g e

Evidence-Based Clinical Practice Guideline. Treatment & Management of Ocular Disease

Principal Benefits for Kaiser Permanente Traditional HMO (1/1/16 12/31/16)

Your guide to Bupa Premier Network SECI Operatives Scheme. Effective from 1 September 2008

Oncology Programme 2015

LAWS OF ALASKA AN ACT

The Courageous Leadership Conference

STATUTORY INSTRUMENTS. S.I. No. 531 of 2018 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) (NO. 2) REGULATIONS 2018

CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY

PROPOSED REGULATION OF THE BOARD OF HEARING AID SPECIALISTS. LCB File No. R February 29, 2000

HIVCare Programme 2017

Minnesota State Board of Assessors

Effective Shared Care Agreement for the treatment of severe motor complications in people with Parkinson Disease with apomorphine (APO-go )

ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies

Occupational Health and Safety Act, 1993

FINAL MAY 2017 Novo Nordisk Scandinavia AB Methodology Note - reporting year 2016 ( Methodology ) Preamble General Summary...

LETTER OF REQUEST: OFFICERS

Dear Potential Childminder Thank you for your interest in registering as a childminder. Please see the following pages:

Consultation on proposed changes to prescribed qualifications

Is your civic address visible What if I call 911 by mistake? when a person doesn t speak from the street? English or French Children and 911

Development Bank of Southern Africa Amendment Bill [B ]

Controlled Drugs Accountable Officers Network Scotland Executive Group. Gabapentin and Pregabalin - Frequently Asked Questions

Changes to Australian Government Hearing Services Program and Voucher scheme

STATUTORY INSTRUMENTS. S.I. No. 599 of 2015 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) REGULATIONS 2015

IC Applicability Sec. 1. The definitions in this chapter apply throughout this article. As added by P.L , SEC.8.

ISA 540, Auditing Accounting Estimates, Including Fair Value Accounting Estimates, and Related Disclosures Issues and Task Force Recommendations

HEALTH & SAFETY MANAGEMENT LICENCE SCHEDULES

Caring for someone who has self-harmed or had suicidal thoughts. A family guide

Speech Therapists and Audiologists 2007

Principal benefits for Kaiser Permanente Traditional Plan (10/1/15 9/30/16)

Draft Agreed by Immunologicals Working Party January Adoption by CVMP for release for consultation 12 March 2009

REGULATORY IMPACT STATEMENT and COST-BENEFIT ANALYSIS (RISCBA)

Please note that this draft is incomplete and likely to change before and/or after City Planning Commission review.

[First Reprint] ASSEMBLY, No STATE OF NEW JERSEY. 217th LEGISLATURE INTRODUCED FEBRUARY 4, 2016

APA Feedback on the Consultation Paper: Establishment of a Central Adelaide Local Health Network Allied Health Structure

Schedule 1. New marketing authorisation and renewal of marketing authorisation

Medical Practitioners 2007

Transcription:

Private Bag X34, HATFIELD, 0028 Hadefields Block E, 1267 Pretorius Street, HATFIELD Phone: +27 (0) 12 431-0500 Fax: +27 (0) 12 430-7644 Http://www.medicalschemes.com To: All medical schemes, administrators, health care provider organizations and other interested parties Telephone: 012 431 0507 / 033 701 1693 Fax: 012 430 7644 / 033 701 1695 Enquiries: Stephen Harrison Date: 16 May 2005 CIRCULAR 18 OF 2005 National Health Reference Price List: Draft changes for Version 2.06 1. It is our intention to release a new version of the National Health Reference Price List (NHRPL) on Tuesday 24 May 2005, with changes to take effect on Wednesday 1 June 2005. 2. The changes which we intend to make in Version 2.06 are described in this circular. Comments are invited on these changes by no later than close of business on Friday 20 May 2005 after which we will finalise the changes for the new version taking into account any comments received. 3. Medical Practitioner s Schedule a. Modifier 0017 The existing wording has created confusion, as in 2005 GP consultations received a rand conversion factor (RCF) which was different to the general consultative services RCF of R9.20. The stated NHRPL value of R69.00 is in fact correct as modifier 0075 should correctly be 7.5 units X general consultative services RCF. The descriptor of the code has therefore been amended to read: 0017 Injections administered by practitioners: When desensitisation, intravenous, intramuscular or subcutaneous injections are administered by the practitioner him-/herself to patients who attend the consulting rooms, a first injection forms part of the consultation/visit and only all subsequent injections for the same condition should be charged at 7.50 consultative services units using modifier 0017 to reflect the amount (not chargeable together with a consultation item) b. Materials and Consumables Codes There have been ongoing industry concerns about the implementability of the structure of the materials codes specifically the separate code provided for dispensing cost of medicines; and the fact that inadequate accommodation is made for different rules that may apply to Schedule

0 and Schedule 1 medicines, on the one hand, and other scheduled medicines on the other. The following revised structure has therefore been proposed to provide for a more rational approach to these codes. II. Medicine, material, supplies and equipment II.a Medicine codes II.a.1 Dispensing of medicine by licensed dispensing medical practitioners 0193 Medical practitioners that are licensed to dispense: Dispensing cost for Schedule 0 or unscheduled medicine: Charge for registered Schedule 0 or unscheduled medicine, identified by the appropriate medicine Nappi code, dispensed according to the Single Exit Price (SEP) or wholesale price PLUS dispensing cost at R26,00 for medicine with a cost of R100,00 or more (VAT inclusive), or 26% for medicine costing less than R100,00 (VAT inclusive) PLUS VAT on the 26%/R26,00. 0197 Medical practitioners that are licensed to dispense: Dispensing cost for Schedule 1 and higher medicine. Charge for Schedule 1 and higher dispensed medicine, identified by the appropriate medicine Nappi code, according to the Single Exit Price (SEP) PLUS the dispensing cost of R16,00 for medicine with a cost of R100,00 or more (VAT inclusive), or 16% for medicine costing less than R100,00 (VAT inclusive) PLUS VAT on the 16%/R16,00. II.a.2 Once-off administration of medicine used during a consultation 0195 Once-off administration of Schedule 0 or unscheduled medicine (Medical practitioners with or without dispensing licenses): This item provides for Schedule 0 or unscheduled medicine used during a consultation, viz, once-off administration of medicine, or special medicine used during treatment. Charge for medicine used, identified by the appropriate medicine Nappi code, according to the Single Exit Price (SEP) PLUS handling fee of R26,00 for medicine with a cost of R100,00 or more, or 26% for medicine costing less than R100,00 PLUS VAT on the 26%/R26,00 0198 Once-off administration of Schedule 1 and higher medicine during a consultation: This item provides for medicine used during a consultation, viz, once-off administration of medicine, or special medicine used during a consultation. Charge for medicine used, identified by the appropriate medicine Nappi code, according to the Single Exit Price (SEP) PLUS R16,00 for medicine with a cost of R100,00 or more, or 16% for medicine costing less than R100,00 PLUS VAT on the 16%/R16,00. II.a.3 Cost of chemotherapy drugs 0212 Cost of chemotherapy drugs: Charge for chemotherapy drugs used during treatment, identified by the appropriate medicine Nappi code, at cost price PLUS R16,00 for medicine with a cost of R100,00 and more (VAT inclusive), or 16% for medicine costing less that R100,00 (VAT inclusive) PLUS VAT on the full amount. II.b Material codes II.b.1 Prosthesis and/or internal fixation 0200 Prosthesis and/or internal fixation: Charge for prosthesis and/or internal fixation, identified by the appropriate surgical and material Nappi code, at cost price PLUS a handling fee of 26% (up to a maximum of R26,00) PLUS VAT calculated on the full amount. II.b.2 Cost of material used during a consultation 0201 Cost of material used during a consultation: Charge for material, identified by the appropriate surgical and material Nappi code, at cost price PLUS a handling fee of 26% (up to a maximum of R26,00) PLUS VAT calculated on the full amount. II.c Setting of sterile tray 0202 Setting of sterile tray: A fee of 10,00 clinical procedure units may be charged for the setting of a sterile tray where a sterile procedure is performed in the rooms. Cost of stitching material, if applicable, shall be charged for according to item 0201, as appropriate II.d Own equipment used in treatment 5930 Surgical laser apparatus: Hire fee for own equipment 5932 Candella laser apparatus: Hire fee for own equipment (Rates by arrangement with the scheme concerned)

4. Ambulance Services At present, codes for transportation of blood and blood products are provided only under the private hospitals schedule, despite the fact that a separate BHF practice type ( 003 ) has been created for Accredited Blood and Blood Product Couriers. We intend to include a new set of codes for this practice type under the ambulance services schedule, restricted to providers with a 003 practice type. However, given the limited supplier market at present, it is not possible to determine an average cost base on which to determine reference prices. These codes will therefore be zero-rated until market conditions change. Medical schemes must therefore take a decision whether to pay suppliers in terms of the new codes, and prices must be determined by arrangement between supplier and individual funder. The new zero-rated codes in the ambulance services schedule are as follows: 7 BLOOD TRANSPORTATION Items in this section on blood transportation are only chargeable by providers with a "003" practice number (Accredited Blood and Blood Product Couriers) 700 Routine "compat" collection: Collection of patient's blood compat by courier from hospital/clinic at a regular predetermined collection time. Compat to be taken to blood bank for cross match. 710 Routine blood/blood product collection: Collection of cross-matched blood/blood product by courier from blood bank at a regular pre-determined collection time. Blood/blood product to be taken to hospital/clinic for patient. 720 Non-routine "compat" collection: Collection of blood compat by courier from hospital/clinic, on a non-routine basis, i.e. where required for clinical reasons to make the collection at any time other than a regular predetermined collection time. Compat to be taken to blood bank for cross-match. 730 Non-routine blood/blood product collection: Collection of cross-matched or ordered blood/blood product by courier from blood bank, on a non-routine basis, i.e. where required for clinical reasons to make the collection at any time other than a regular predetermined collection time. Blood/blood product to be taken to hospital/clinic for patient. 740 Long distance: Additional per km fee for collections further than 50km. This fee applies only to those kilometres in excess of 50 km. Supporting documentation required, illustrating distance traveled. 5. Chiropractors a. Rule 003 Prior notification was given of an error in the wording of rule 003, which should have made reference to three, rather than two diagnostic procedures. This has now been corrected. Rule 003 now reads: 003 A maximum of three diagnostic procedures may be charged at the same consultation or visit. Diagnostic procedures include physical examination, neurological examination, orthopaedic examination, ergonomical analysis, postural analysis and radiological examination

b. X-Ray films In the last version change, X-ray films were specifically included under the materials code (100). This continued to create problems because many medical schemes have an automatic NAPPI code required rule for this code, and X-rays do not have NAPPI codes. We therefore intend to create a separate code 110 for X-rays. The consumables section will now read as follows: 5 Consumables The amount charged in respect of medicines and scheduled substances shall not exceed the limits prescribed in the Regulations Relating to a Transparent Pricing System for Medicines and Scheduled Substances, dated 30 April 2004, made in terms of the Medicines and Related Substances Act, 1965 (Act No 101 of 1965). In relation to all other materials, items are to be charged (exclusive of VAT) at net acquisition price plus - * 26% of the net acquisition price where the net acquisition price of that material is less than one hundred rands; and * a maximum of twenty six rands where the net acquisition price of that material is greater than or equal to one hundred rands. 100 Medication / material: Charge for medication or material, identified by the appropriate Nappi code. 110 X-Ray films 6. Biokinetics Prior notification was given of an error in the wording of rule 003, which should have made reference to three, rather than two diagnostic procedures. This has now been corrected. Rule 003 now reads: 003 A maximum of three diagnostic procedures may be charged at the same consultation or visit. Diagnostic procedures include the full range of diagnostic and evaluation procedures within the scope of practice of the biokineticist, including for example: anthropometric / body composition assessments, ergological testing evaluations and perceptual motor evaluation. 7. Occupational and Art Therapy In the merger of the two schedules, a value for code 401 was inadvertently omitted in respect of art therapists. This was a technical error which has now been rectified. Code 401 now has the VAT inclusive (VAT exclusive) values of R42.50 (R37.30) for both occupational therapists and art therapists. 8. Registered Nurses in Private Practice and Nursing Agencies Due to amendments to the Medicines and Related Substances Control Act, 101 of 1965, reference to a section 22A(12) permit should now refer to a section 22A(15) permit. This affects rule 09 and item 454 of the nursing schedule, and these items will be amended accordingly. Section 22A(15) of Act 101 of 1965 reads as follows:

(15) Notwithstanding anything to the contrary contained in this section, the Director-General may, after consultation with the Interim Pharmacy Council of South Africa as referred to in section 2 of the Pharmacy Act, 1974 (Act 53 of 1974), issue a permit to any person or organisation performing a health service, authorising such person or organisation to acquire, possess, use or supply any specified Schedule 1, Schedule 2, Schedule 3, Schedule 4 or Schedule 5 substance, and such permit shall be subject to such conditions as the Director-General may determine. Sincerely Stephen Harrison SENIOR SPECIALIST: POLICY AND SPECIAL PROJECTS